BioHarvest Sciences Inc. files Form 6-K current reports as a foreign issuer, with exhibits that document company announcements and material changes. These filings cover the company's Botanical Synthesis platform, its VINIA-branded nutraceutical products, CDMO activities for plant-based compounds, earnings-call announcements, and business updates.
The filing record also includes governance and capital-structure subjects such as board composition changes, executive leadership transitions, long-term incentive awards, stock options, restricted share units, and equity incentive plan activity. Together, the disclosures provide formal records of BioHarvest's operating focus, public-company governance, compensation structure, and recurring communications to the market.
BioHarvest Sciences Inc. (BHST) has filed a Form S-8 registering securities that may be issued under its 2025 Equity Incentive Plan. The company is a Canadian non-accelerated filer, smaller reporting registrant and emerging-growth company. O’Neill Law LLP is named as agent for service. Documents incorporated by reference include the FY-2024 Form 40-F, various Form 6-Ks and the Form 8-A describing BHST’s common shares. Exhibits comprise the legal opinion, auditor consent, the plan document, powers of attorney and the filing-fee table.
The statement contains customary indemnification provisions for directors and officers under British Columbia’s Business Corporations Act and standard undertakings to update or withdraw unsold shares. The filing was signed on 22 July 2025 by CEO Ilan Sobel, CFO Bar Dichter and the full board, with a U.S. representative signing in Nevada.